Hsbc Holdings PLC Sells 26,843 Shares of Pediatrix Medical Group, Inc. $MD

Hsbc Holdings PLC trimmed its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 23.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 88,822 shares of the company’s stock after selling 26,843 shares during the period. Hsbc Holdings PLC owned about 0.11% of Pediatrix Medical Group worth $1,890,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Wasatch Advisors LP bought a new position in shares of Pediatrix Medical Group in the 1st quarter worth approximately $43,861,000. Allspring Global Investments Holdings LLC bought a new stake in Pediatrix Medical Group during the fourth quarter valued at approximately $13,613,000. Rockefeller Capital Management L.P. increased its holdings in Pediatrix Medical Group by 814.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock valued at $12,713,000 after buying an additional 529,367 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Pediatrix Medical Group by 175.4% during the second quarter. Ameriprise Financial Inc. now owns 744,473 shares of the company’s stock valued at $10,683,000 after buying an additional 474,186 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its position in Pediatrix Medical Group by 669.4% in the second quarter. BNP Paribas Financial Markets now owns 476,098 shares of the company’s stock worth $6,832,000 after acquiring an additional 414,216 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Insider Activity at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the firm’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

MD has been the topic of several analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, June 24th. Mizuho set a $24.00 price objective on Pediatrix Medical Group in a research note on Friday, May 8th. Truist Financial raised their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. UBS Group lifted their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $23.33.

Pediatrix Medical Group Trading Down 0.1%

Shares of MD stock opened at $26.25 on Monday. Pediatrix Medical Group, Inc. has a 12-month low of $11.84 and a 12-month high of $27.94. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The stock’s 50-day moving average price is $24.17 and its 200-day moving average price is $22.34. The stock has a market capitalization of $2.16 billion, a price-to-earnings ratio of 12.74 and a beta of 0.66.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The business had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter last year, the business posted $0.33 EPS. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.